Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI heart helper: will doctors use it?

NCT ID NCT07405866

Knowledge-focused Sponsor: Heart Input Output Inc Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether doctors would use an AI program called ECGio to help decide care for patients who might have heart artery disease. About 10,000 adults with risk factors like high blood pressure or diabetes will be included. The main goal is to see how often doctors choose to use the AI tool in their regular practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 10,000 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Feb 2026

An estimate. Start dates often move.

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This study will be conducted in patients who fall within the guidelines for referral to calcium scoring and present at the Cardiology Consultant's of Philadelphia's Advanced Access Center, or present at one of their clinics for pre-operative screening.

Ages

18 to 89 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years. * Patients with medical records stored in a digitized format. * Presenting between February 1 2026 and October 31 2026. * Patient meets one of the following criteria: * Hypertension * Hyperlipidemia * Family History of Disease * Diabetes Mellitus * High BMI (\>30) * Smoker (Former or Current) * Presenting for pre-operative clearance Exclusion Criteria: * Patients with acute coronary syndrome (ACS). * Patient with prior Coronary Artery Bypass Grafting (CABG) * Patients whose ECG tracing has extreme noise or artifact to the extent that it would be recommended to redo the tracing. * Age ≥ 90 years.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ai-algorithm usage are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Ai-algorithm usage

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Cardiology Consultants of Philadelphia

    Philadelphia, Pennsylvania, 19148, United States

  • Cardiology Consultants of Philadelphia - Chestnus St

    Philadelphia, Pennsylvania, 19107, United States

  • Cardiology Consultants of Philadelphia - Rothman Orthopedics

    Bensalem, Pennsylvania, 19020, United States

  • Cardiology Consultants of Philadelphia - Sproul

    Springfield, Pennsylvania, 19064, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.